Filing Details
- Accession Number:
- 0001179110-20-004985
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-20 16:38:35
- Reporting Period:
- 2020-04-16
- Accepted Time:
- 2020-04-20 16:38:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1477449 | Teladoc Health Inc. | TDOC | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 043705970 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1726568 | Lewis Levy | C/O Teladoc Health, Inc. 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-04-16 | 1,395 | $35.45 | 5,775 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-04-16 | 5,661 | $38.55 | 11,436 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-04-16 | 2,670 | $165.93 | 8,766 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-04-16 | 1,395 | $0.00 | 1,395 | $35.45 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-04-16 | 5,661 | $0.00 | 5,661 | $38.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,833 | 2027-07-14 | No | 4 | M | Direct | |
29,089 | 2028-03-01 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 13, 2020.
- The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
- The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.